Wyss InstituteLiving Cellular Devices – Wyss Institute

Tooling up to diagnose ocean health

Jessica Leff — Thu, 05 Feb 2026 14:55:24 +0000

By Benjamin Boettner (BOSTON) — Oceanic ecosystems are increasingly threatened by global warming, which causes coral bleaching, species migration, and, through the loss of habitats and biodiversity, food web disruptions on major scales. Also, pollutants such as plastics and other marine debris, wastewater, and chemical runoffs, including oil spills, cause major ecosystem disruptions.

Source

Engineering Living Materials with Peter Q. Nguyen

Jessica Leff — Wed, 24 Sep 2025 16:13:25 +0000

In this episode of the CoreSpin Podcast Interview Series, host Misha Bagirov sits down with Wyss Senior Scientist Peter Q. Nguyen, Ph.D., to explore how synthetic biology can turn biofilms into useful materials, embed cell-free systems into wearables (like COVID-sensing masks), and program probiotics as future therapeutics. We also talked about the philosophy behind bioengineering…

Source

Hani Sallum on Engineering Prototypes for Researchers, Patients, and the Planet

Jessica Leff — Wed, 30 Oct 2024 13:00:46 +0000

The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. Hani Sallum is always tinkering, whether he’s creating an eight-foot-tall robot costume to show off at a convention or designing a carbon dioxide-powered seawater collection system to…

Source

Preventing pollution with bioinspired solutions

Jessica Leff — Tue, 17 Sep 2024 21:14:47 +0000

By Lindsay Brownell In honor of Pollution Prevention Week, we’re highlighting three Wyss projects that are taking on the formidable problems of PFAS and plastic – persistent and toxic pollutants that threaten the health of humans, animals, and ecosystems. Per- and polyfluoroalkyl substances (PFAS), or “forever chemicals,” are toxic substances that increase the risk of many health…

Source

AminoX: Making Better Protein Drugs, Quicker and Cheaper

Jessica Leff — Wed, 10 Jul 2024 13:56:00 +0000

A synthetic biology and advanced chemistry platform that efficiently incorporates non-standard amino acids by hacking the ubiquitous protein synthesis process. Credit: Wyss Institute at Harvard University…

Source

Instrument-Free Molecular Diagnostics

Mariel Schoen — Wed, 01 May 2024 17:25:23 +0000

Molecular diagnostics is the fastest-growing segment of the global in vitro diagnostics market, but the vast majority of these tests require expensive equipment and supplies, limiting their use to medical facilities. There is a large unmet need for cheap, readily accessible, accurate diagnostic tests that can be deployed in non-clinical settings to address threats to public health…

Source

AminoX: Making Better Protein Drugs, Quicker and Cheaper

Jessica Leff — Wed, 01 May 2024 15:40:43 +0000

Protein drugs often offer the most effective way to treat a variety of medical illnesses and conditions. However, many proteins in their naturally occurring forms make poor drugs – they can cause toxicities that force patients to discontinue treatment, and they often have such short half-lives that patients would need to receive a constant infusion of them to see a therapeutic effect. Recently…

Source

Engineered Live Biotherapeutic Product (eLBP) to Protect the Microbiome from Antibiotics

Jessica Leff — Wed, 01 May 2024 14:44:43 +0000

Antibiotics not only kill the pathogenic bacteria causing an infection, they also indiscriminately wreak havoc on the trillions of “good” bacteria making up the human microbiome. Known as “dysbiosis,” this alteration of our gut microbial composition manifests as discomforting diarrhea in up to 35% of patients in the short term, and can take months to resolve, often requiring dietary corrections…

Source

Paper-Based Diagnostics

admin — Wed, 01 May 2024 00:34:41 +0000

With the imminent threat of new pandemics and frequent disease outbreaks exemplified by the recent Ebola and Zika epidemics, there is a growing need for low-cost, easily deployable and simple-to-use diagnostic tools. The Wyss Institute has developed paper-based synthetic gene networks as a next generation diagnostic technology for use in global healthcare crises and patient care. This new type of…

Source

Wyss Institute’s AminoX project receives funding from Northpond Labs to accelerate innovation in protein-based therapeutics

Mariel Schoen — Mon, 08 Apr 2024 14:55:29 +0000

By Lindsay Brownell (BOSTON) — The Wyss Institute for Biologically Inspired Engineering at Harvard University and Northpond Ventures announced today that the VC firm’s affiliate Northpond Labs has signed an agreement to support the development of the AminoX project toward commercialization. This is the fourth Wyss project selected by Northpond Labs for additional funding.

Source